Living with anxiety disorders: as good as it gets...?

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Bulletin of the Menninger Clinic

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  PMID 11002527
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• What treatments do patients with panic disorder and agoraphobia get?

  2005cited by this paper
• The Arizona Sexual Experience Scale (ASEX): reliability and validity.

  2000cited by this paper
• Mirtazapine substitution in SSRI-induced sexual dysfunction.

  2000cited by this paper
• A 40-year follow-up of patients with obsessive-compulsive disorder [see commetns].

  1999cited by this paper
• Olanzapine addition in obsessive-compulsive disorder refractory to selective serotonin reuptake inhibitors: an open-label case series.

  1999cited by this paper
• Phenelzine-induced sexual dysfunction treated with sildenafil.

  1999cited by this paper
• Sildenafil treatment of serotonin reuptake inhibitor-induced sexual dysfunction.

  1999cited by this paper
• Sildenafil treatment of paroxetine-induced anorgasmia in a woman.

  1999cited by this paper
• Relief of SSRI-induced sexual dysfunction with mirtazapine treatment.

  1999cited by this paper
• Sildenafil for iatrogenic serotonergic antidepressant medication-induced sexual dysfunction in 4 patients.

  1999cited by this paper
• The economic burden of anxiety disorders in the 1990s.

  1999cited by this paper
• Oral phentolamine and female sexual arousal disorder: a pilot study.

  1999cited by this paper
• Ginkgo biloba for antidepressant-induced sexual dysfunction.

  1998cited by this paper
• Why patients use alternative medicine: results of a national study.

  1998cited by this paper
• Herbal remedies in psychiatric practice.

  1998cited by this paper
• Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey.

  1998cited by this paper
• An Open Trial of Oral Sildenafilin Antidepressant-Induced Sexual Dysfunction

  1998cited by this paper
• Prevalence of anxiety disorders and their comorbidity with mood and addictive disorders

  1998cited by this paper
• Cardiac complications and delirium associated with valerian root withdrawal.

  1998cited by this paper
• Bupropion as an antidote for serotonin reuptake inhibitor-induced sexual dysfunction.

  1998cited by this paper
• Depression and anxiety: implications for nosology, course, and treatment.

  1997cited by this paper
• Mirtazapine: An Antidepressant with Noradrenergic and Specific Serotonergic Effects

  1997cited by this paper
• A critical review of selective serotonin reuptake inhibitor-related sexual dysfunction; incidence, possible aetiology and implications for management

  1997cited by this paper
• Sertraline-induced anorgasmia treated with intermittent nefazodone.

  1997cited by this paper
• Mirtazapine: pharmacology in relation to adverse effects

  1997cited by this paper
• Management of co-morbid anxiety and alcohol disorders: parallel treatment of disorders.

  1997cited by this paper
• Mianserin, a 5-HT2a/2c and alpha 2 antagonist, in the treatment of sexual dysfunction induced by serotonin reuptake inhibitors.

  1997cited by this paper
• Treatment-emergent changes in sexual function with selective serotonin reuptake inhibitors as measured with the Rush Sexual Inventory.

  1997cited by this paper
• SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients.

  1997cited by this paper
• Resolution of fluoxetine-induced sexual dysfunction with the 5-HT3 antagonist granisetron.

  1997cited by this paper
• Augmentation strategies: focus on anxiolytics.

  1996cited by this paper
• Response to an open trial of a second SSRI in major depression.

  1996cited by this paper
• Panic disorder: diagnosis, epidemiology, and clinical course.

  1996cited by this paper
• Why do patients turn to complementary medicine? An empirical study.

  1996cited by this paper
• Intermittent amantadine for fluoxetine-induced anorgasmia.

  1996cited by this paper
• Phenomenology and Course of Generalised Anxiety Disorder

  1996cited by this paper
• Cyproheptadine treatment of sexual dysfunction induced by serotonin reuptake inhibitors.

  1995cited by this paper
• Amantadine in the treatment of sexual dysfunction associated with selective serotonin reuptake inhibitors.

  1995cited by this paper
• Selective serotonin reuptake inhibitor-induced sexual dysfunction: efficacy of a drug holiday.

  1995cited by this paper
• Psychostimulants apparently reverse sexual dysfunction secondary to selective serotonin re-uptake inhibitors.

  1995cited by this paper
• Anxiety symptom relief in depression treatment outcomes.

  1995cited by this paper
• Trazodone and spontaneous orgasms in an elderly postmenopausal woman: a case report.

  1995cited by this paper
• Antidepressant-induced orgasm disorder.

  1995cited by this paper
• Female Sexual Side Effects Associated with Selective Serotonin Reuptake Inhibitors: A Descriptive Clinical Study of 33 Patients

  1995cited by this paper
• Synaptosomal GABA release as influenced by valerian root extract--involvement of the GABA carrier.

  1994cited by this paper
• Psychotropic medications and their effects on sexual function: diagnosis, biology, and treatment approaches.

  1994cited by this paper
• Toxicological Problems Resulting from Exposure to Traditional Remedies and Food Supplements

  1994cited by this paper
• Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey.

  1994cited by this paper
• Vasculitis associated with herbal preparation containing Passiflora extract.

  1993cited by this paper
• Antidepressants for the treatment of generalized anxiety disorder. A placebo-controlled comparison of imipramine, trazodone, and diazepam.

  1993cited by this paper
• Improvement in fluoxetine-associated sexual dysfunction in patients switched to bupropion.

  1993cited by this paper
• Fluoxetine-induced sexual dysfunction and an open trial of yohimbine.

  1992cited by this paper
• Yohimbine treatment of sexual side effects induced by serotonin reuptake blockers.

  1992cited by this paper
• Possible trazodone potentiation of fluoxetine: a case series.

  1992cited by this paper
• Buspirone in major depression: a controlled study.

  1991cited by this paper
• Effect of buspirone on sexual dysfunction in patients with generalized anxiety disorder.

  1987cited by this paper
• Alprazolam, diazepam, imipramine, and placebo in outpatients with major depression.

  1987cited by this paper
• Anorgasmia from Clomipramine in Obsessive-Compulsive Disorder

  1987cited by this paper
• Cyproheptadine and Antidepressant-induced Anorgasmia

  1986cited by this paper
• Psychiatric disorders in primary care. Results of a follow-up study.

  1985cited by this paper
• Inhibition by certain plant extracts of the binding and adenylate cyclase stimulatory effect of bovine thyrotropin in human thyroid membranes.

  1984cited by this paper
• Utilization of health and mental health services. Three Epidemiologic Catchment Area sites.

  1984cited by this paper
• Anxiety syndromes and their relationship to depressive illness.

  1983cited by this paper
• Comparison of alprazolam, imipramine, and placebo in the treatment of depression.

  1983cited by this paper

• Anxiety and depression in Canada during the COVID-19 pandemic: A national survey.

  2020cites this paper
• Mobilizing Minds: Integrated knowledge translation and youth engagement in the development of mental health information resources

  2016cites this paper
• Gaps in accessing treatment for anxiety and depression: challenges for the delivery of care.

  2004cites this paper
• The nature of anxiety and depression: Implications for prevention.

  2004cites this paper